Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Rochester, NY
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Asheville, NC
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Salisbury, NC
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Salisbury, NC
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Winston-Salem, NC
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Cleveland, OH
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Dayton, OH
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Mentor, OH
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Mentor, OH
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Tulsa, OK
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Portland, OR
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Malvern, PA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Malvern, PA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Warwick, RI
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Mount Pleasant, SC
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chattanooga, TN
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Hermitage, TN
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Hermitage, TN
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Houston, TX
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Irving, TX
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Southlake, TX
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
West Jordan, UT
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Alexandria, VA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Virginia Beach, VA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Bellevue, WA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Seattle, WA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Madison, WI
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Decatur, AL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Decatur, AL
Click here to add this to my saved trials
Development of a Novel Human In Vitro Sarcoidosis Model
Development of a Novel Human In Vitro Sarcoidosis Model
Status: Enrolling
Updated:  9/2/2014
Biomedical Research Tower, 10th floor
mi
from
Columbus, OH
Development of a Novel Human In Vitro Sarcoidosis Model
Development of a Novel Human In Vitro Sarcoidosis Model
Status: Enrolling
Updated: 9/2/2014
Biomedical Research Tower, 10th floor
mi
from
Columbus, OH
Click here to add this to my saved trials
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial
Status: Enrolling
Updated:  9/3/2014
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial
Status: Enrolling
Updated: 9/3/2014
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial
Status: Enrolling
Updated:  9/3/2014
Aurora St.Luke's Medical Center
mi
from
Milwaukee, WI
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA
Comparison of "Wet Suction" Technique to Contemporary "Dry Suction" Technique Using a 22 Gauge Needle for EUS FNA of Solid Lesions. A Randomized, Prospective, Blinded, and Controlled Trial
Status: Enrolling
Updated: 9/3/2014
Aurora St.Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Status: Enrolling
Updated:  9/17/2014
Kennedy Krieger Institute
mi
from
Baltimore, MD
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Status: Enrolling
Updated: 9/17/2014
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Status: Enrolling
Updated:  9/17/2014
Johns Hopkins Hospital
mi
from
Baltimore, MD
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Status: Enrolling
Updated: 9/17/2014
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Status: Enrolling
Updated:  9/17/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Status: Enrolling
Updated: 9/17/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism
Pilot Study to Study the Effects of the Food Preservative Calcium Propionate on Postprandial Hormonal and Metabolic Milieu
Status: Enrolling
Updated:  9/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism
Pilot Study to Study the Effects of the Food Preservative Calcium Propionate on Postprandial Hormonal and Metabolic Milieu
Status: Enrolling
Updated: 9/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Status: Enrolling
Updated:  9/20/2014
Joslin Diabetes Center
mi
from
Boston, MA
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Status: Enrolling
Updated: 9/20/2014
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Acupuncture for Reduction of Inflammation
Acupuncture for Reduction of Inflammation in Thyroid and Parathyroid Surgery
Status: Enrolling
Updated:  10/7/2014
University Hospital
mi
from
Newark, NJ
Acupuncture for Reduction of Inflammation
Acupuncture for Reduction of Inflammation in Thyroid and Parathyroid Surgery
Status: Enrolling
Updated: 10/7/2014
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
Metformin Therapy for Overweight Adolescents With Type 1 Diabetes (T1D)--Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
Status: Enrolling
Updated:  10/22/2014
Jaeb Center for Health Research
mi
from
Tampa, FL
Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
Metformin Therapy for Overweight Adolescents With Type 1 Diabetes (T1D)--Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
Status: Enrolling
Updated: 10/22/2014
Jaeb Center for Health Research
mi
from
Tampa, FL
Click here to add this to my saved trials
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Status: Enrolling
Updated:  10/22/2014
Celerion
mi
from
Lincoln, NE
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Status: Enrolling
Updated: 10/22/2014
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
Effects of Sleep Duration and Architecture on Insulin Sensitivity
Effects of Sleep Duration and Architecture on Insulin Sensitivity
Status: Enrolling
Updated:  10/25/2014
UCSF San Francisco General Hospital
mi
from
San Francisco, CA
Effects of Sleep Duration and Architecture on Insulin Sensitivity
Effects of Sleep Duration and Architecture on Insulin Sensitivity
Status: Enrolling
Updated: 10/25/2014
UCSF San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV-infected Persons
Metabolic Abnormalities in HIV-infected Persons
Status: Enrolling
Updated:  11/13/2014
Tufts Medical Center
mi
from
Boston, MA
Metabolic Abnormalities in HIV-infected Persons
Metabolic Abnormalities in HIV-infected Persons
Status: Enrolling
Updated: 11/13/2014
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
Comparing the Overall Efficacy of Endoscopic Ultrasound Fine Needle Aspiration Versus Fine Needle Biopsy in the Diagnosis of Solid Lesions: A Multicenter, Randomized Clinical Trial
Status: Enrolling
Updated:  11/18/2014
Stony Brook University Hospital
mi
from
Stony Brook, NY
Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
Comparing the Overall Efficacy of Endoscopic Ultrasound Fine Needle Aspiration Versus Fine Needle Biopsy in the Diagnosis of Solid Lesions: A Multicenter, Randomized Clinical Trial
Status: Enrolling
Updated: 11/18/2014
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Status: Enrolling
Updated:  12/4/2014
University of South Florida
mi
from
Tampa, FL
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Status: Enrolling
Updated: 12/4/2014
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Metabolically Normal and Metabolically Abnormal Obesity
Metabolically Normal and Metabolically Abnormal Obesity
Status: Enrolling
Updated:  12/30/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Metabolically Normal and Metabolically Abnormal Obesity
Metabolically Normal and Metabolically Abnormal Obesity
Status: Enrolling
Updated: 12/30/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
Status: Enrolling
Updated:  1/23/2015
Albany Medical College
mi
from
Albany, NY
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
Status: Enrolling
Updated: 1/23/2015
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
Status: Enrolling
Updated:  1/23/2015
Albany Medical College
mi
from
Albany, NY
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
Status: Enrolling
Updated: 1/23/2015
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated:  3/3/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated: 3/3/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated:  3/3/2015
Clinical Research Facility
mi
from
Seattle, WA
Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated: 3/3/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Status: Enrolling
Updated:  4/8/2015
Clinical Research Facility
mi
from
Santa Barbara, CA
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Status: Enrolling
Updated: 4/8/2015
Clinical Research Facility
mi
from
Santa Barbara, CA
Click here to add this to my saved trials